We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Bristol-Myers Squibb Co on Thursday reported a swing to a first-quarter loss on charges related to its acquisition of ...
Bristol-Myers Squibb on Monday said it has signed an agreement to expedite the manufacturing of its CAR-T cell therap ...
ibb Co - New York-based pharmaceutical company - Completes acquisition of Karuna Therapeutics Inc, a Massachusetts-bas ...
Bristol-Myers Squibb Co on Friday reported stronger fourth-quarter revenue, with sales from new drug launches increas ...
Bristol-Myers Squibb Co on Tuesday announced that the European Medicines Agency had validated an application for a lu ...
Bristol-Myers Squibb Co on Tuesday announced its second large acquisition in four days, saying it has agreed to buy N ...
Bristol-Myers Squibb Co on Friday agreed to buy biopharmaceutical company Karuna Therapeutics Inc for USD14.0 billion ...
A number of leading pharmaceutical companies on Monday reported positive trial results on the treatment of lymphoma, ...
Drug maker Bristol-Myers Squibb Co on Thursday said it will repurchase another batch of its shares. It authorised a ...
ibb Co - Princeton, New Jersey-based pharmaceutical company - Receives manufacturing and marketing approval of the sup ...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.69 | 1.24683773039 | 55.34 | 57.39 | 54.71 | 6304 | 55.8869078 | DE |
4 | 7.815 | 16.2086487608 | 48.215 | 58.32 | 48.045 | 10726 | 53.6000989 | DE |
12 | 10.565 | 23.2376553393 | 45.465 | 58.32 | 43.01 | 7988 | 49.73866701 | DE |
26 | 17.81 | 46.5986394558 | 38.22 | 58.32 | 36.315 | 10312 | 43.66290898 | DE |
52 | 10.53 | 23.1428571429 | 45.5 | 58.32 | 36.315 | 10841 | 44.17879548 | DE |
156 | 5.35 | 10.5564325178 | 50.68 | 80.5 | 36.315 | 4921 | 48.40611698 | DE |
260 | 4.58 | 8.90184645287 | 51.45 | 80.5 | 36.315 | 4430 | 50.06819808 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions